|
Volumn 32, Issue 9, 2012, Pages 2957-2958
|
Successful treatment of azole-resistant Candida spondylodiscitis with high-dose caspofungin monotherapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
C REACTIVE PROTEIN;
CASPOFUNGIN;
CD4 ANTIGEN;
CREATININE;
PYRROLE;
ADULT;
ANTIFUNGAL SUSCEPTIBILITY;
BACKACHE;
BLOOD CULTURE;
CANDIDA ALBICANS;
CANDIDA SPONDYLODISCITIS;
CASE REPORT;
CD4 LYMPHOCYTE COUNT;
COMPUTER ASSISTED TOMOGRAPHY;
CREATININE BLOOD LEVEL;
DISEASE DURATION;
ESOPHAGITIS;
FUNGUS CULTURE;
FUNGUS GROWTH;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFLAMMATORY CELL;
INTERVERTEBRAL DISK DEGENERATION;
LETTER;
MALE;
MONOTHERAPY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PERIODIC ACID SCHIFF STAIN;
PRIORITY JOURNAL;
SPINE RADIOGRAPHY;
ADULT;
ANTIFUNGAL AGENTS;
AZOLES;
CANDIDA ALBICANS;
CANDIDIASIS;
DISCITIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE, FUNGAL;
ECHINOCANDINS;
HIV INFECTIONS;
HUMANS;
IMMUNOCOMPROMISED HOST;
MALE;
THORACIC VERTEBRAE;
TREATMENT OUTCOME;
|
EID: 84866434325
PISSN: 01728172
EISSN: 1437160X
Source Type: Journal
DOI: 10.1007/s00296-011-2121-6 Document Type: Letter |
Times cited : (7)
|
References (9)
|